| 000 | 01159 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513150346.0 | ||
| 264 | 0 | _c19981028 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0268-1315 | ||
| 024 | 7 |
_a10.1097/00004850-199804004-00004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDunner, D L | |
| 245 | 0 | 0 |
_aThe issue of comorbidity in the treatment of panic. _h[electronic resource] |
| 260 |
_bInternational clinical psychopharmacology _cApr 1998 |
||
| 300 |
_aS19-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntidepressive Agents _xadverse effects |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDepressive Disorder, Major _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPanic Disorder _xdiagnosis |
| 650 | 0 | 4 |
_aPrimary Health Care _xstatistics & numerical data |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aWorld Health Organization |
| 773 | 0 |
_tInternational clinical psychopharmacology _gvol. 13 Suppl 4 _gp. S19-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004850-199804004-00004 _zAvailable from publisher's website |
| 999 |
_c9656631 _d9656631 |
||